Tender Overview
The Indian Army under the Department Of Military Affairs invites bids for a diverse range of medical products, including various tablets, syrups, injections, creams, and disposable syringes. The procurement covers 22 items with an estimated value of ₹67,733.40. Items span anti-diabetic, analgesic, thyroid, urological, dermatological, hematological, and supportive medical supplies, plus disposable medical devices. The tender emphasizes continuous service support via a dedicated toll-free channel and indicates a broad catalog rather than a single-brand mandate. The geographic scope is not clearly specified, but this aligns with national defense medical provisioning. The unique aspect is the broad, multi-item medical supply scope targeting Army medical kits and routine pharmaceutical needs, with an emphasis on reliable after-sales support.
Technical Specifications & Requirements
- No explicit technical specifications are published in the tender data. The BOQ lists 22 items with placeholders (N/A), suggesting a catalog-based supply rather than itemized performance criteria. Estimated value indicates a modest procurement scale. The absence of standard references means bidders should anticipate generic pharmaceutical compliance. The buyer highlights a dedicated service channel for post-sale support, implying a need for responsive service capability and OEM-based support arrangements.
- Potential product categories include: SITAGLIPTIN 50 MG TAB, SODIUM VALPROATE 500 MG TAB, SOLIFENACIN 5 MG TAB, TAMSULIN/DUTASTERIDE combo, TOLVAPTAN, DICLOFENAC GEL, and injectable syringes. Bidders should prepare to cover a wide range of packaging formats, dosages, and associated delivery terms, alongside basic regulatory compliance.
Terms, Conditions & Eligibility
- Dedicated toll-free service for post-sale support is required for bidder/OEM.
- No explicit EMD amount or payment milestones published; bidders should seek clarification on security deposits.
- No dates or delivery windows specified; bidders must verify delivery timelines and installation requirements with the buyer.
- Documentation expectations (GST, PAN, vendor registrations) are not enumerated in the text; historically these are standard in government pharma tenders. Ensure readiness for typical KYC, financials, and experience proofs.
- The tender lists 22 items; confirmation of OEM authorizations and pharmaceutical licenses may be required at bid submission.
- Overall, bidders should prepare for general compliance, with emphasis on after-sales support and catalog-based delivery readiness.
